The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

neopharma.se

Founded Year

1994

Stage

Acquired | Acquired

Total Raised

$4.7M

About NeoPharma

Provider of patent-protected pharmaceutical formulations and systems, primarily for the treatment of Parkinson’s disease. The company will provide medicines, administration and information systems to improve quality of life for patients and health economy for society. [Keywords: patient care]

NeoPharma Headquarter Location

Box 22

Uppsala, 751 03,

Sweden

46 18 17 29 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NeoPharma Patents

NeoPharma has filed 1 patent.

The 3 most popular patent topics include:

  • Cattle breeds
  • Cow's-milk cheeses
  • EC 2.1.1
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/13/2020

3/15/2022

Cow's-milk cheeses, Nutrition, Milk, Cattle breeds, EC 2.1.1

Grant

Application Date

2/13/2020

Grant Date

3/15/2022

Title

Related Topics

Cow's-milk cheeses, Nutrition, Milk, Cattle breeds, EC 2.1.1

Status

Grant

Latest NeoPharma News

In reopening Tennessee penicillin plant, Jackson Healthcare relieves the US' dependence on China-made antibiotics

Aug 30, 2021

Aug 30, 2021 11:26am Earlier this year, President Joe Biden directed his administration to review U.S. supply chains. In a move that will relieve U.S. dependence on China for penicillin, Jackson Healthcare has reopened a plant in Bristol, Tennessee. (Fierce Healthcare) Supply chain disruptions during the coronavirus pandemic highlighted a key vulnerability for countries like the United States, which have come to rely on overseas sources for certain medicines and the raw materials to produce them. So on Monday, when a penicillin plant in Tennessee  reopened after slipping into bankruptcy a year ago, officials were sure to highlight the significance of the site's turnaround. Instead of simply pointing out the benefits of a commerce surge that typically comes with the opening of a business venture, attendees Tennessee Gov. Bill Lee and Rep. Diana Harshbarger could wax with some justification about the necessity of domestic manufacturing and ownership. Jackson Healthcare of Georgia is reopening the Bristol plant, which was formerly owned by Neopharma, under the name of USAntibiotics. The 360,000-square foot factory will churn out enough Amoxil and Augmentin to stockpile the U.S. for five years, the company said in a release. In all, it'll produce 2 billion tablets and 300 million capsules annually. Last August, Neopharma of the United Arab Emirates declared bankruptcy and shuttered the 43-year-old plant, leaving the U.S. dependent solely on penicillin from China. During the pandemic, Chinese-made products such as ventilators and masks were in short supply in the U.S., highlighting the need for flexible, domestic manufacturing. “The reconstruction of our domestic manufacturing capability for life-saving penicillin is a national imperative,” Harshberger said earlier this year. “Our reliance on China and foreign-sourced raw materials for antibiotic production presents a severe deficiency in the reliability of the supply chain and actively undermines our national security and public health interests.”     After the plant’s prior closure, Harshberger lobbied the U.S. Cybersecurity and Infrastructure Security Agency (CISA) to retain its critical infrastructure designation.

  • When was NeoPharma founded?

    NeoPharma was founded in 1994.

  • Where is NeoPharma's headquarters?

    NeoPharma's headquarters is located at Box 22, Uppsala.

  • What is NeoPharma's latest funding round?

    NeoPharma's latest funding round is Acquired.

  • How much did NeoPharma raise?

    NeoPharma raised a total of $4.7M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.